loadpatents
name:-0.019240140914917
name:-0.01476001739502
name:-0.011157035827637
Patient; Lee Patent Filings

Patient; Lee

Patent Applications and Registrations

Patent applications and USPTO patent grants for Patient; Lee.The latest application filed is for "therapeutic compound and use in therapy".

Company Profile
12.16.22
  • Patient; Lee - Linton GB
  • Patient; Lee - Cambridge GB
  • Patient; Lee - Cambridge Cambridgeshire GB
  • Patient; Lee - London GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
CXCR4 receptor antagonists
Grant 10,995,091 - Savory , et al. May 4, 2
2021-05-04
Process for the preparation of (3S,4S)-tetrahydrofuran-3-yl 4-isopropyl-6,7-dihydro-3H-imidazo[4,5-C]pyridine-5(4H)-carboxylate
Grant 10,988,473 - Horgan , et al. April 27, 2
2021-04-27
Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors
Grant 10,968,223 - Espensen , et al. April 6, 2
2021-04-06
Therapeutic Compound And Use In Therapy
App 20210024518 - Patient; Lee
2021-01-28
Imidazo[4,5-c]pyridine And Pyrrolo[2,3-c]pyridine Derivatives As Ssao Inhibitors
App 20200347059 - ESPENSEN; Max ;   et al.
2020-11-05
Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors
Grant 10,766,897 - Espensen , et al. Sep
2020-09-08
Compounds
App 20200262835 - ESPENSEN; Max ;   et al.
2020-08-20
Therapeutic compound and use in therapy
Grant 10,738,044 - Patient A
2020-08-11
Compounds
Grant 10,590,125 - Espensen , et al.
2020-03-17
Process For The Preparation Of (3s,4s)-tetrahydrofuran-3-yl 4-isopropyl-6,7-dihydro-3h-imidazo[4,5-c]pyridine-5(4h)-carboxylate
App 20200062746 - HORGAN; Anne ;   et al.
2020-02-27
Imidazo[4,5-c]pyridine And Pyrrolo[2,3-c]pyridine Derivatives As Ssao Inhibitors
App 20200002335 - ESPENSEN; Max ;   et al.
2020-01-02
Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors
Grant 10,428,066 - Espensen , et al. October 1, 2
2019-10-01
New Therapeutic Compound And Use In Therapy
App 20190185467 - PATIENT; Lee
2019-06-20
Cxcr4 Receptor Antagonists
App 20190062333 - SAVORY; Edward Daniel ;   et al.
2019-02-28
CXCR4 receptor antagonists
Grant 10,155,761 - Savory , et al. Dec
2018-12-18
Substituted imidazo[4,5-c]pyridines as SSAO inhibitors
Grant 10,065,954 - Espensen , et al. September 4, 2
2018-09-04
Imidazo[4,5-c]pyridine And Pyrrolo[2,3-c]pyridine Derivatives As Ssao Inhibitors
App 20180194763 - Espensen; Max ;   et al.
2018-07-12
Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors
Grant 9,951,068 - Espensen , et al. April 24, 2
2018-04-24
Imidazo[4,5-c]pyridine Derived Ssao Inhibitors
App 20170362218 - Espensen; Max ;   et al.
2017-12-21
Imidazo[4,5-c]pyridine Derived Ssao Inhibitors
App 20170275281 - Patient; Lee ;   et al.
2017-09-28
Imidazo[4,5-c]pyridine And Pyrrolo[2,3-c]pyridine Derivatives As Ssao Inhibitors
App 20170247378 - Espensen; Max ;   et al.
2017-08-31
CXCR4 Receptor Antagonists
App 20170226106 - Savory; Edward Daniel ;   et al.
2017-08-10
Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors
Grant 9,676,769 - Espensen , et al. June 13, 2
2017-06-13
Compounds
Grant 9,580,415 - Patient , et al. February 28, 2
2017-02-28
New Compounds
App 20160326172 - Espensen; Max ;   et al.
2016-11-10
Substituted imidazo[4,5-c]pyridine compounds and compositions thereof
Grant 9,428,498 - Espensen , et al. August 30, 2
2016-08-30
CXCR4 receptor antagonists
Grant 9,353,086 - Savory , et al. May 31, 2
2016-05-31
Imidazo[4,5-c]pyridine And Pyrrolo[2,3-c]pyridine Derivatives As Ssao Inhibitors
App 20160046622 - Espensen; Max ;   et al.
2016-02-18
CXCR4 Receptor Antagonists
App 20160046606 - Savory; Edward Daniel ;   et al.
2016-02-18
New Compounds
App 20160024080 - Patient; Lee ;   et al.
2016-01-28
New Compounds
App 20140275040 - Espensen; Max ;   et al.
2014-09-18
CXCR4 Receptor Antagonists
App 20130289020 - Savory; Edward Daniel ;   et al.
2013-10-31
Tetrahydrofuro[3,2-b] pyrrol-3-one intermediates
Grant 8,039,641 - Quibell , et al. October 18, 2
2011-10-18
Tetrahydrofuro[3,2-b] pyrrol-3-one intermediates
App 20090192322 - Quibell; Martin ;   et al.
2009-07-30
Biologically active compounds
App 20090131502 - Quibell; Martin ;   et al.
2009-05-21
Azacyclic compounds as inhibitors of sensory neurone specific channels
App 20070043024 - Hamlyn; Richard John ;   et al.
2007-02-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed